Exodus Point Capital Management, LP Ngm Biopharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $185,988 - $705,228	54,542 Added 103.55%	107,214 $538,000
Q3 2022 Nov 10, 2022	BUY	$12.59 - $17.67 $663,140 - $930,714	52,672 New	52,672 $689,000
Q1 2022 May 13, 2022	SELL	$13.81 - $18.6 $281,627 - $379,309	-20,393 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$17.26 - $22.02 $351,983 - $449,053	20,393 New	20,393 $361,000
Q4 2019 Feb 14, 2020	SELL	$9.97 - $20.28 $173,478 - $352,872	-17,400 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$13.09 - $18.19 $227,766 - $316,506	17,400 New	17,400 $241,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.